Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Canadian Blood Services, commonly referred to as CBS, is a prominent non-profit organisation headquartered in Canada. Established in 1998, it plays a vital role in the country's healthcare system by managing the collection, testing, and distribution of blood and blood products across major regions in Canada. Operating within the 'Other services (93)' industry, CBS is dedicated to ensuring a safe and reliable supply of blood, plasma, and stem cells for patients in need.
The organisation's core services centre on voluntary blood donation and the provision of specialised products such as plasma and stem cells, which are essential for treating a range of medical conditions. Recognised for its commitment to safety and innovation, Canadian Blood Services holds a leading position in Canada's healthcare landscape, supporting life-saving treatments and advancing research initiatives.
+9 vs industry average
Canadian Blood Services’s score of 34 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Other Services has below-average carbon intensity
The Other Services industry has reduced its overall emissions by 37% since 2018
Scope 3 accounts for ••• of total emissions.
Canadian Blood Services, operating in the "Other services (93)" industry from its headquarters in CA, has demonstrated a commitment to reducing its environmental impact. In the reporting year 2024, the organisation reported total emissions of approximately 37.1 million kg CO2e, comprising Scope 1 emissions of about 9.5 million kg CO2e, Scope 2 emissions of approximately 6.1 million kg CO2e, and Scope 3 emissions of about 21.5 million kg CO2e.
The organisation has achieved a significant reduction in its overall emissions, reporting a 14% decrease in total market-based emissions between the 2019-2020 period and the 2023-2024 reporting year. This reduction applies to both Scope 1 and Scope 2 emissions. For instance, Scope 1 emissions in 2023 were approximately 9.1 million kg CO2e, down from 9.6 million kg CO2e in 2022. Scope 2 emissions also saw a decrease, from about 7.1 million kg CO2e in 2022 to approximately 6.1 million kg CO2e in 2024. While Scope 3 emissions in 2024 were reported at around 21.5 million kg CO2e, they have fluctuated over the years, with figures such as 1.9 million kg CO2e in 2023 and 678,000 kg CO2e in 2022.
Further details regarding emission reduction targets are available in their sustainability reports, with specific focus on achieving a 14% reduction in total market-based emissions from 2019-2020 levels by 2024. Canadian Blood Services also provides emission intensity metrics, such as total kilograms of CO2e per weighted unit, indicating ongoing efforts to monitor and manage their carbon footprint.
Access structured emission data, company specific factors and auditable source documents
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more